JOHNSON & JOHNSON Last 5 Year Stock GraphThe above graph shows the monthly share price for Johnson & Johnson over the graph period. The share price tells us how much it would cost to buy one share in the company and the graph highlights recent trends. The company’s title is Johnson & Johnson, and the company was set up in 1887. The official company’s blueprint for success is as follows: Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific. The company is a behemoth in the industry, boasting a market capitalization that makes it one of the largest in the world. Its market cap is427608369570. This metric is derived by multiplying the number of available shares by the current share price, representing the company’s market value. Johnson & Johnson – Financial OverviewThe company is currently trading at -10.03% below its 52-week high. The 52 week high provides interested parties with the idea of how much the security has moved in the last year and whether it is trading near this high. The price to earnings ratio of the company is 33.3403, this number indicates the amount a company earns compared to the price it costs to buy the company. Some investors would see a low price to earnings ratio provides as providing value. Analysts will usually compare price to earnings ratio of companies within the same industry group. Companies with high price to earnings ratio are considered as growth stocks, whilst companies with low price to earnings ratio are considered as value stocks. The beta of Johnson & Johnson is 0.5358, this is a technical term for the level of volatility a company has when compared to the overall market. The S&P 500 has a beta of 1, so stocks with beta values greater than 1 tend to move with more momentum when compared to the overall stock market and is therefore more volatile than the overall stock market. Whilst betas of less than 1 signal that the stock is less volatile than the market and may be safer, in times of uncertainty, certain investors will increase the number of stocks that have betas less than one. Johnson & Johnson – Investment ProfitsIf you would have invested $100 in JOHNSON & JOHNSON 5 years ago today, you would have made a profit of $21.02. Johnson & Johnson – Key Metrics Updated DailyOfficial Name Johnson & Johnson Beta: 0.5358 52 Week High: 181.039 52 Week Low: 150.11 Change: -1.49 Number of Employees: 152700 Exchange: New York Stock Exchange Headquarters: One Johnson & Johnson Plaza, NEW BRUNSWICK, NJ, 08933 US Industry: Pharmaceuticals Year incorporated: 1887
Johnson & Johnson – What to look out for in 2023Here are 10 key bullet points to consider when investing in Johnson & Johnson: |
